List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 104 studies with search of: "Meningioma"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Biobank Meningioma: Storing Blood for Analysis of DNA and Protein of Patients With Meningioma
Condition: Meningioma
Intervention:
2 Recruiting Monthly SOM230C for Recurrent or Progressive Meningioma
Condition: Meningioma
Intervention: Drug: SOM230C
3 Recruiting Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma
Conditions: CNS Cancer;   Meningioma;   Intracranial Hemangiopericytoma;   Hemangioblastoma;   Neurofibromatosis
Intervention: Drug: Sunitinib
4 Active, not recruiting Stereotactic Radiosurgery in Treating Patients With Brain Tumors
Conditions: Adult Central Nervous System Germ Cell Tumor;   Adult Malignant Meningioma;   Adult Medulloblastoma;   Adult Noninfiltrating Astrocytoma;   Adult Oligodendroglioma;   Adult Craniopharyngioma;   Adult Meningioma;   Brain Metastases;   Adult Ependymoma;   Adult Pineal Parenchymal Tumor;   Adult Brain Stem Glioma;   Adult Infiltrating Astrocytoma;   Mixed Gliomas;   Stage IV Peripheral Primitive Neuroectodermal Tumor
Intervention: Procedure: Sterotactic radiosurgery
5 Recruiting Combination of Hydroxyurea and Verapamil for Refractory Meningiomas
Conditions: Cancer;   Brain Cancer;   Meningioma
Interventions: Drug: Hydroxyurea;   Drug: Verapamil
6 Not yet recruiting Observation or Radiation Therapy in Treating Patients With Grade I, Grade II, or Grade III Meningioma
Condition: Brain and Central Nervous System Tumors
Interventions: Procedure: observation;   Radiation: 3-dimensional conformal radiation therapy;   Radiation: intensity-modulated radiation therapy
7 Completed Imatinib Mesylate in Treating Patients With Recurrent Meningioma
Condition: Brain and Central Nervous System Tumors
Intervention: Drug: imatinib mesylate
8 Recruiting Imatinib Mesylate and Hydroxyurea in Treating Patients With Recurrent or Progressive Meningioma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: hydroxyurea;   Drug: imatinib mesylate
9 Active, not recruiting Hydroxyurea in Treating Patients With Recurrent and/or Unresectable Meningioma
Condition: Brain and Central Nervous System Tumors
Intervention: Drug: hydroxyurea
10 Active, not recruiting Interferon Alfa in Treating Patients With Recurrent Unresectable Meningiomas and Malignant Meningiomas
Condition: Brain and Central Nervous System Tumors
Intervention: Biological: recombinant interferon alfa
11 Recruiting Sunitinib in Treating Patients With Recurrent or Unresectable Meningioma, Intracranial Hemangiopericytoma, or Intracranial Hemangioblastoma
Conditions: Brain and Central Nervous System Tumors;   Neurofibromatosis Type 1 (nf1);   Neurofibromatosis Type 2 (nf2);   Precancerous/Nonmalignant Condition
Intervention: Drug: sunitinib malate
12 Recruiting Vatalanib in Treating Patients With Recurrent or Progressive Meningioma
Conditions: Brain and Central Nervous System Tumors;   Sarcoma
Intervention: Drug: vatalanib
13 Recruiting Radiation Therapy in Treating Patients Who Have Undergone Surgery for Newly Diagnosed Grade II or Grade III Meningioma
Condition: Brain and Central Nervous System Tumors
Interventions: Procedure: adjuvant therapy;   Radiation: radiation therapy
14 Completed Hydroxyurea in Treating Patients With Unresectable Benign Meningioma
Condition: Brain and Central Nervous System Tumors
Intervention: Drug: hydroxyurea
15 Active, not recruiting Antineoplaston Therapy in Treating Patients With Meningioma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
16 Active, not recruiting Ph II Imatinib Mesylate + Hydroxyurea in Treatment for Pts w Recurrent/Progressive Meningioma
Conditions: Glioblastoma;   Gliosarcoma
Intervention: Drug: Imatinib Mesylate and Hydroxyurea
17 Active, not recruiting Phase II Study of SOM230 in Patients With Recurrent or Progressive Meningioma
Condition: Cancer
Intervention: Drug: SOM230B
18 Active, not recruiting NF2 Natural History Consortium
Conditions: Schwannoma, Vestibular;   Neurofibromatosis 2;   Meningioma
Intervention:
19 Active, not recruiting Radiotherapy or Radiosurgery Compared With Observation Alone in Treating Patients With Newly Diagnosed, Benign Meningioma That Has Been Partially Removed by Surgery
Condition: Brain and Central Nervous System Tumors
Interventions: Procedure: adjuvant therapy;   Radiation: radiation therapy;   Radiation: stereotactic radiosurgery
20 Withdrawn Ifosfamide in Treating Patients With Meningeal Tumors
Conditions: Chondrosarcoma;   Adult Fibrosarcoma;   Adult Leiomyosarcoma;   Adult Rhabdomyosarcoma;   Adult Malignant Meningioma;   Adult Brain Malignant Hemangiopericytoma
Interventions: Drug: ifosfamide;   Procedure: chemotherapy

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services